| Trial ID: | L0834 |
| Source ID: | NCT02983669
|
| Associated Drug: |
Thyme
|
| Title: |
The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Biochemical Markers and Imaging Studies of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
ThymeLiv
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver;Fatty Liver, Nonalcoholic;Fatty Liver;Fatty Liver, Nonalcoholic;Fatty Liver;Fatty Liver, Nonalcoholic;Fatty Liver;Fatty Liver, Nonalcoholic
|
| Interventions: |
Dietary Supplement: Thyme;Other: Placebo;Dietary Supplement: Thyme;Other: Placebo;Dietary Supplement: Thyme;Other: Placebo;Dietary Supplement: Thyme;Other: Placebo
|
| Outcome Measures: |
Change in ALT (Alanin aminotransferase) level;Change in grade of fatty liver in sonography by use of Saverymuttu Scoring System;Change in ALT (Alanin aminotransferase) level;Change in grade of fatty liver in sonography by use of Saverymuttu Scoring System;Change in ALT (Alanin aminotransferase) level;Change in grade of fatty liver in sonography by use of Saverymuttu Scoring SystemChange in AST (Aspartate aminotransferase) level;Fasting blood sugar (FBS);Change in Gama GT (?-glutamyl transpeptidase) level;Fasting insulin level;Body weight;Waist circumference;Hip circumference;Number of patients with adverse events
|
| Sponsor/Collaborators: |
Shiraz University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 Years65 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
86
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
02/12/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
16 December 2017
|
| Locations: |
Iran, Islamic Republic of;Iran, Islamic Republic of;Iran, Islamic Republic of;Iran, Islamic Republic of;Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02983669
|
